Abhinandan Anand Raman, MD
Infectious Disease · Stockton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 9 years
- Graduated 2017
Offices
1 location · Touro University Medical Group · 23 clinicians in this group
Hospitals listed: St Joseph'S Medical Center of Stockton. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Raman’s office at (209) 943-2000 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- St Joseph'S Medical Center of StocktonStockton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 67% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.08, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.34, Oct 2024 – Sep 2025
See every measure and the patient survey for St Joseph'S Medical Center of Stockton
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.08 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.34 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.51 (0.54 to 2.47) · 1,424 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.78 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.22 (98.08 to 180.36) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 127 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 98 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.9 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.2 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.4 · 405 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9 · 337 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,812 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.09 to 0.49) · 6,528 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,304 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.48 (1.49 to 5.48) · 1,467 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.27 (0 to 2.79) · 464 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.22 (0.81 to 3.64) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.16 (1.3 to 13.02) · 455 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.22 (1.5 to 8.93) · 456 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.24 (0.78 to 3.71) · 262 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.03 (0.53 to 1.53) · 6,521 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.537 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.486 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.646 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 484 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 878 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.2 · 265 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 17.1 · 493 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 407 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 615 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 14.1 · 184 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 164 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 290 cases | No different | Jan 2024 – Dec 2024 |
What patients said (541 patients answered, 14% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$16,376
Medicare paid this office $16,376 for 106 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 65 | $6,842 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $4,635 | $62 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $718 | $60 |
Who their Medicare patients are
106 Original Medicare patients in 2024. Average age 70 · Under 65 26% · Women 47% · Also on Medicaid 76% · Health risk score 4.05. Above the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Diabetes 62% · Chronic kidney disease 62% · Heart failure 57% · Coronary heart disease 46% · Atrial fibrillation 43% · COPD 38% · Depression 36% · Stroke 27% · Dementia 25% · Cancer 13%.
The office billed $51,897, Medicare allowed $20,623 and paid $16,376; for 197 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Medicaid work
$1,464 in 2024
Medicaid paid $1,464 for 28 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 14 | $1,010 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 14 | $454 |
| 2024 | 28 | 2 | 14 | $1,464 |
Drugs they prescribed that Part D paid
$296,155
Pharmacies billed $296,155 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 174) in 2024. At or below the middle of the specialty; the typical infectious disease clinician is at 0%.
97 generic and 77 brand-name prescriptions · $296,155 in drug cost · 66 antibiotic prescriptions to 21 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Biktarvy | 52 | $204,332 | $3,929 |
| Cefadroxil | 17 | $473 | $28 |
| Doxycycline Hyclate | 23 | $368 | $16 |
| Atorvastatin | 12 | $62 | $5 |
Year by year
| 2024 | 174 | 38 | 0% (0) | 44% | $296,155 |
| 2023 | 147 | 27 | 0% (0) | 60% | $307,803 |
| 2022 | 51 | 15 | 0% (0) | 24% | $25,276 |
| 2021 | 433 | 76 | 0% (0) | 33% | $106,790 |
| 2020 | 662 | 91 | 0% (0) | 28% | $129,972 |
| 2019 | 75 | 26 | 0% (0) | None | $6,342 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Biktarvy | 55 | $220,172 | $4,003 |
| Prezcobix | 13 | $32,009 | $2,462 |
| Tivicay | 13 | $28,574 | $2,198 |
| Doxycycline Hyclate | 12 | $842 | $70 |
2021: 11 drugs
| Novolog Flexpen | 13 | $10,347 | $796 |
| Lantus Solostar | 18 | $8,584 | $477 |
| Albuterol Sulfate Hfa | 21 | $1,113 | $53 |
| Nifedipine Er | 18 | $996 | $55 |
| Comfort Ez Pen Needle | 12 | $955 | $80 |
| Atorvastatin | 32 | $393 | $12 |
| Pantoprazole | 13 | $270 | $21 |
| Pen Needles | 11 | $254 | $23 |
| Amlodipine Besylate | 12 | $58 | $5 |
| Metformin | 13 | $50 | $4 |
| Single Use Swab | 13 | $26 | $2 |
2020: 18 drugs
| Novolog Mix 70-30 Flexpen | 12 | $11,899 | $992 |
| Symbicort | 21 | $7,166 | $341 |
| Janumet | 11 | $5,291 | $481 |
| Basaglar Kwikpen U-100 | 13 | $4,645 | $357 |
| Incruse Ellipta | 14 | $4,137 | $295 |
| Albuterol Sulfate Hfa | 38 | $1,897 | $50 |
| Nifedipine Er | 27 | $1,029 | $38 |
| Atorvastatin | 42 | $365 | $9 |
| Alcohol Prep Pads | 21 | $320 | $15 |
| Enalapril Maleate | 13 | $175 | $13 |
| Losartan | 16 | $170 | $11 |
| Metformin | 30 | $116 | $4 |
| Pantoprazole | 25 | $112 | $4 |
| Gabapentin | 11 | $85 | $8 |
| Tamsulosin | 14 | $68 | $5 |
| Montelukast | 12 | $62 | $5 |
| Lisinopril | 14 | $35 | $2 |
| Amlodipine Besylate | 11 | $33 | $3 |
Money from drug and device companies
$331 in 2025
A payment is not proof that care is biased.
| Astellas Pharma US | None | $80 | 1 payment
|
| Janssen Biotech | Erleada | $80 | 2 payments
|
| Abbvie | Emblaveo | $66 | 1 payment
|
| Merck Sharp & Dohme | Zerbaxa | $56 | 2 payments
|
| Procept Biorobotics | Aquabeam Robotic System | $29 | 1 payment
|
| Urogen Pharma | None | $20 | 1 payment
|
See all 8 published payments
| Abbvie | Meals · 2025-12-10 | Emblaveo | $66 |
| Urogen Pharma | Meals · 2025-11-26 | None | $20 |
| Janssen Biotech | Meals · 2025-10-16 | Erleada | $45 |
| Astellas Pharma US | Education · 2025-10-16 | None | $80 |
| Merck Sharp & Dohme | Meals · 2025-05-27 | Zerbaxa | $34 |
| Janssen Biotech | Meals · 2025-05-07 | Erleada | $35 |
| Merck Sharp & Dohme | Meals · 2025-04-25 | Zerbaxa | $22 |
| Procept Biorobotics | Meals · 2025-01-28 | Aquabeam Robotic System | $29 |
Professional record
- NPI
- 1003478819
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X)
- Mailing address
- 1805 N California St Ste 201, Stockton, CA, 95204
- NPI first listed
- 2019-07-01
- NPI last updated
- 2024-11-08
- NPI record certified
- 2024-11-08
This is when the NPI record was last certified, not a medical board exam.